MichaelSHershfieldMD
Rheumatology • Durham, NCProfessor, Medicine, Duke University School of Medicine
Are you Dr. Hershfield?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 52 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4101 N Roxboro St
Durham, NC 27704Phone+1 919-684-8111
Summary
- Dr. Michael Hershfield, MD is a rheumatologist in Durham, North Carolina. He is currently licensed to practice medicine in North Carolina. He is affiliated with Durham Veterans Affairs Medical Center and is a Professor at Duke University School of Medicine.
Education & Training
University of California (San Diego) Medical CenterResidency, Internal Medicine, 1974 - 1975
Philadelphia General HospitalInternship, Transitional Year, 1967 - 1968
Perelman School of Medicine at the University of PennsylvaniaClass of 1967
Certifications & Licensure
NC State Medical License 1976 - 2023
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1980
Publications & Presentations
PubMed
- 86 citationsTreating gout with pegloticase, a PEGylated urate oxidase, provides insight into the importance of uric acid as an antioxidant in vivoMichael S. Hershfield, L. Jackson Roberts, Nancy J. Ganson, Susan J. Kelly, Ines Santisteban
Proceedings of the National Academy of Sciences of the United States of America. 2010-08-10 - 24 citationsLong-term outcomes after gene therapy for adenosine deaminase severe combined immune deficiencyBryanna Reinhardt, Omar Habib, Kit L. Shaw, Elizabeth Garabedian, Denise A. Carbonaro-Sarracino
Blood. 2021-10-14 - 80 citationsCD28 costimulatory signal induces protein arginine methylation in T cellsFabien Blanchet, Ana Cardona, Fabrice A. Letimier, Michael S. Hershfield, Oreste Acuto
The Journal of Experimental Medicine. 2005-08-01
Press Mentions
Fact-Checking, Pros and Cons of Cord Blood BankingJanuary 19th, 2021
ADA2 Deficiency: Case Series of Five Patients with Varying PhenotypesDecember 17th, 2019
Idiopathic, Refractory Sweet's Syndrome Associated with Common Variable Immunodeficiency: A Case Report and Literature ReviewMay 14th, 2019- Join now to see all
Grant Support
- Peg-Uricase As Therapy For Refractory GoutFood And Drug Administration2004–2006
- A Lymphoblast Model For Diseases Of Purine MetabolismNational Institute Of Diabetes And Digestive And Kidney Diseases1986–2006
- Lymphoblast Model For Diseases Of Purine MetabolismNational Institute Of Diabetes And Digestive And Kidney Diseases1994–2001
- Mammalian PEG Uricase For Therapy Of Intractable GoutNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1997
- Mammalian PEG Uricase For Therapy Of Intractable GoutNational Institute Of Diabetes And Digestive And Kidney Diseases1994
- A Lymphoblast Model For Diseases Of MetabolismNational Institute Of Diabetes And Digestive And Kidney Diseases1991–1993
- Lymphoblast Model For Diseases Of MetabolismNational Institute Of Diabetes And Digestive And Kidney Diseases1992
- Mechanism Of Immunopharmacologic Purine AnalogsNational Institute Of Allergy And Infectious Diseases1986–1990
- A Lymphoblast Model For Diseases Of Purine MetabolismNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985
Professional Memberships
- Member
- Master Member
